UPDATE 1-Novartis raises full-year outlook, boosted by Diovan

* Q2 core EPS down 4 pct at $1.30 vs $1.34 in Reuters poll
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.